# US 2016/0354508 A1 · Method for preparing wound dressing material using biopolymer and wound dressing material using biopolymer prepared thereby

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354508 A1
- Document ID: US20160354508A1
- Status: Published application
- Kind: A1
- Application number: 15/033,187
- Filed: 2016-01-22
- Published: 2016-12-08
- Earliest claimed: 2015-01-30
- Assignees: Meditip Co., Ltd.
- Applicants: Meditip Co., Ltd.
- Inventors: Jeoung Hee Yoo
- Web page: https://patentgrep.com/patent/US20160354508A1

## CPC

- A61L 15/44: Medicaments
- A61K 31/7036: having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
- A61K 31/728: Hyaluronic acid
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 15/46: Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A61L 31/042: {Polysaccharides}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61L 2300/406: Antibiotics
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed is a method for preparing a wound dressing material using a biopolymer, wherein the wound dressing material prepared by the method can have excellent effects of inhibiting wound infections and preventing adhesions.

## Claims

### Claim 1

A method for preparing a dressing material for inhibiting wound infections and preventing adhesions, the method comprising:
preparing a solution using an antibiotic and hyaluronic acid or a salt thereof;
freezing the prepared solution under rotation; and
drying the frozen solution.

### Claim 2 (depends on 1)

The method of claim 1, wherein the solution has a pH of 4.0-8.0.

### Claim 3 (depends on 1)

The method of claim 1, wherein the salt of hyaluronic acid is at least one selected from the group consisting of sodium hyaluronate, potassium hyaluronate, calcium hyaluronate, magnesium hyaluronate, zinc hyaluronate, cobalt hyaluronate, and tetrabutyl ammonium hyaluronate.

### Claim 4 (depends on 1)

The method of claim 1, wherein the molecular weight of the hyaluronic acid is 10,000-3,000,000 Da.

### Claim 5 (depends on 1)

The method of claim 1, wherein the concentration of the hyaluronic acid is 0.1-5% (w/v).

### Claim 6 (depends on 1)

The method of claim 1, wherein the antibiotic is at least one selected from the group consisting of cephalosporin-based, β-lactam-based, aminoglycoside-based, macrolide-based, quinolone-based, and tetracycline-based antibiotics.

### Claim 7

A method for preparing a dressing material for inhibiting wound infections and preventing adhesions, the method comprising:
i) preparing a solution using an antibiotic and hyaluronic acid or a salt thereof;
ii) freezing the prepared solution;
ii) thawing the frozen solution;
iv) refreezing the thawed solution; and
v) drying the re-frozen solution.

### Claim 8 (depends on 7)

The method of claim 7, wherein the solution has a pH of 4.0-8.0.

### Claim 9 (depends on 7)

The method of claim 7, wherein the salt of hyaluronic acid is at least one selected from the group consisting of sodium hyaluronate, potassium hyaluronate, calcium hyaluronate, magnesium hyaluronate, zinc hyaluronate, cobalt hyaluronate, and tetrabutyl ammonium hyaluronate.

### Claim 10 (depends on 7)

The method of claim 7, wherein the molecular weight of the hyaluronic acid is 10,000 to 3,000,000 Da.

### Claim 11 (depends on 7)

The method of claim 7, wherein the concentration of the hyaluronic acid is 0.1-5% (w/v).

### Claim 12 (depends on 7)

The method of claim 7, wherein the antibiotic is at least one selected from the group consisting of cephalosporin-based, β-lactam-based, aminoglycoside-based, macrolide-based, quinolone-based, and tetracycline-based antibiotics.

### Claim 13 (depends on 7)

The method of claim 7, wherein steps ii) to iii) are repeated two to six times.

### Claim 14

A method for preparing a dressing material for inhibiting wound infections and preventing adhesions, the method comprising:
i) preparing a solution using an antibiotic and hyaluronic acid or a salt thereof;
ii) leaving the prepared solution at a low temperature for 8 hours;
iii) freezing the solution left at a low temperature; and
iv) drying the frozen solution.

### Claim 15 (depends on 14)

The method of claim 14, wherein the solution has a pH of 4.0-8.0.

### Claim 16 (depends on 14)

The method of claim 14, wherein the salt of hyaluronic acid is at least one selected from the group consisting of sodium hyaluronate, potassium hyaluronate, calcium hyaluronate, magnesium hyaluronate, zinc hyaluronate, cobalt hyaluronate, and tetrabutyl ammonium hyaluronate.

### Claim 17 (depends on 14)

The method of claim 14, wherein the molecular weight of the hyaluronic acid is 10,000 to 3,000,000 Da.

### Claim 18 (depends on 14)

The method of claim 14, wherein the concentration of the hyaluronic acid is 0.1-5% (w/v).

### Claim 19 (depends on 14)

The method of claim 14, wherein the antibiotic is at least one selected from the group consisting of cephalosporin-based, β-lactam-based, aminoglycoside-based, macrolide-based, quinolone-based, and tetracycline-based antibiotics.

### Claim 20 (depends on 14)

The method of claim 14, wherein the low temperature is 0-10° C.
